WELL Health Technologies (TSE:WELL - Free Report) had its price target trimmed by TD Securities from C$8.50 to C$7.50 in a research note released on Wednesday morning,BayStreet.CA reports. The firm currently has a buy rating on the stock.
Several other equities research analysts also recently commented on WELL. Royal Bank of Canada cut their target price on shares of WELL Health Technologies from C$8.50 to C$7.50 and set an "outperform" rating on the stock in a research report on Monday, March 31st. Ventum Financial lifted their price target on shares of WELL Health Technologies from C$7.50 to C$8.00 in a report on Thursday, January 30th. Finally, Raymond James raised their target price on WELL Health Technologies from C$10.00 to C$11.00 in a research report on Tuesday, December 17th. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of C$8.08.
View Our Latest Stock Analysis on WELL Health Technologies
WELL Health Technologies Price Performance
WELL stock traded down C$0.19 during midday trading on Wednesday, reaching C$3.77. 1,110,064 shares of the stock were exchanged, compared to its average volume of 1,005,995. The company has a debt-to-equity ratio of 46.79, a current ratio of 1.14 and a quick ratio of 1.02. The stock has a market capitalization of C$942.21 million, a PE ratio of 12.77, a P/E/G ratio of -1.93 and a beta of 1.20. WELL Health Technologies has a 52 week low of C$3.48 and a 52 week high of C$7.36. The company has a fifty day moving average price of C$5.07 and a 200 day moving average price of C$5.56.
WELL Health Technologies Company Profile
(
Get Free Report)
WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. It provides omni-channel patient services and solutions to specific markets, such as provider staffing, anesthesia, gastrointestinal health, women's health, primary care, and mental healthcare.
Recommended Stories
Before you consider WELL Health Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and WELL Health Technologies wasn't on the list.
While WELL Health Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
